CAMPNASDAQ Global Market·USD·Closed·Healthcare · Biotechnology
CAMP4 Therapeutics Corporation
$4.41−$0.08 · −1.78%day vs prior
Mkt Cap · USD
93.67M
P/E · TTM
-2.0
Div Yield · ann
–
52-week
$1.46 – $7.75
at 47% of range
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.